Want to join the conversation?
$REGN and Sanofi Genzyme said they will present additional data from pivotal Phase 2b Dupilumab study in adults with uncontrolled persistent asthma at the American Thoracic Society International Conference in San Francisco, California from May 13-18.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?